Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Nonselective nitric oxide inhibition should not yet alter shock management; leaves open targeted modulation preserving perfusion benefits.
Shah et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: